Synagis® Palivizumab
For Healthcare Professionals
 
 
 
Synagis Patient
My doctor said my baby should get Synagis. What should I do next?
1
Get all of your baby's Synagis appointments on the calendar.

Try to schedule all of your baby’s Synagis appointments for the season up front. You want to make sure to get every dose that your doctor prescribes and planning ahead can help you stay on track.

Missing or delaying any doses of Synagis means your baby won't have protection from severe RSV disease. Make sure you learn more about RSV and how serious it can be.

2
Understand how Synagis works.

Synagis is not a vaccine, and it works differently. Synagis gives your baby a dose of virus-fighting substances called antibodies to help prevent serious RSV infections. Each dose only works for about 28-30 days, so you don’t want to skip or postpone any shots.

Keep reading to learn more about how Synagis works and why getting every dose at the same time each month is so important.

3
Get support throughout RSV season.

Just getting through RSV season can seem like a challenge, but you’re not alone. You can find support, helpful reminders and even tips from parents who’ve been there in our Helping HandSM program.

Sign up today and we'll help keep your RSV protection plan on track.

How Synagis Works
What Is RSV
Why Monthly Shots
Insurance Coverage
Resources & Support
Get a Helping Hand(SM)
 
 
 
Sign up for information and important reminders.
Share your story with the Thrive Network.
 
 
 
MedImmune

Important Safety Information

Synagis® (palivizumab) is indicated for the prevention of serious lung infections caused by respiratory syncytial virus (RSV) in children at high risk of RSV disease. Synagis is given as a shot, usually in the thigh muscle, each month during the RSV season. The first dose of Synagis should be given before RSV season begins. Children who develop an RSV infection while receiving Synagis should continue the monthly dosing schedule throughout the season. Synagis has been used in more than one million children in the U.S. since its introduction in 1998.

Very rare cases (<1 per 100,000 patients) of severe allergic reactions such as anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. These rare reactions may occur when any dose of Synagis is given, not just the first one. Also, rare but serious side effects can occur, which may lead to unusual bruising and/or groups of pinpoint red spots found on the skin.

Other side effects with Synagis may include upper respiratory tract infection, ear infection, fever, and runny nose. In children born with heart problems, Synagis was associated with reports of low blood oxygen levels and abnormal heart rhythms. Synagis should not be used in patients with a history of a severe prior reaction to Synagis or its components. Side effects, such as, skin reactions around the area where the shot was given (like redness, swelling, warmth, or discomfort) can also occur.

Privacy Policy | Terms and Conditions | Site Map